Published July 14, 2026
Set Your Expectations Now, Because the Internet Is About to Get This Wrong
On Wednesday, July 15, the DEA’s historic rescheduling hearing in Arlington will gavel out. After two weeks of testimony on whether marijuana should move from Schedule I to Schedule III, a lot of people are going to expect an answer.
There won’t be one. Not that day, not that week, and — if history is any guide — possibly not this year.
That’s not pessimism; it’s process. Rescheduling a controlled substance is a formal rulemaking with a series of legally required steps that don’t compress just because everyone’s impatient. So before the “marijuana is rescheduled!” headlines start misfiring on the 15th, here’s the actual roadmap from the hearing’s final gavel to a rule that changes anything — the six stages ahead, how long each realistically takes, and the two wild cards that could speed it up or blow the timeline apart.
First, What July 15 Actually Is
The hearing that ends next week is an evidentiary proceeding, not a verdict. Its entire job is to build a factual record. Presiding chief administrative law judge Derek C. Julius isn’t deciding whether to reschedule — he’s overseeing testimony and cross-examination so that someone else can decide later, on a complete record.
And note who testified: the government (arguing for rescheduling) plus seven selected parties, all opponents — Smart Approaches to Marijuana, the National Drug & Alcohol Screening Association, the Tennessee Bureau of Investigation, four states, and others. Their job was to test the government’s case. When the last witness steps down on the 15th, the record closes. That’s all the 15th is: the end of evidence-gathering.
The Six Steps Between July 15 and Real Rescheduling
Step 1 — Post-hearing briefs. No dramatic closing arguments. Instead, each party files written briefs summarizing their evidence, typically within a few weeks of the record closing. This is where the arguments get distilled for the judge.
Step 2 — The ALJ’s recommended decision. Judge Julius reviews the full record and issues findings plus a recommendation on whether marijuana qualifies for Schedule III. Two things matter enormously here. First, there’s no deadline — Julius faces no legal clock to issue this. Second, it’s a recommendation, not a ruling. It doesn’t bind anyone.
Step 3 — The DEA Administrator’s review. The recommendation goes to DEA Administrator Terry Cole, who weighs it alongside the evidence and the FDA’s scientific assessment. The Administrator can accept the recommendation, modify it, or reject it outright. The proposed rule is for Schedule III, but the DEA could theoretically land on Schedule II or leave marijuana in Schedule I. (More on why that “reject” option isn’t hypothetical in a moment.)
Step 4 — The final rule. If the Administrator decides to proceed, the DEA publishes a final rule in the Federal Register formally changing marijuana’s schedule. This is the step that actually changes the law.
Step 5 — OMB review and effective date. Significant rules typically route through the White House’s Office of Management and Budget before publication, and a final rule usually specifies an effective date some period after it publishes. Rescheduling isn’t real until that date arrives.
Step 6 — The courtroom. Whoever loses sues. If the rule reschedules, opponents challenge it; the anti-rescheduling states and groups have signaled as much, and some are already in the D.C. Circuit fighting April’s medical-cannabis order. A final rule can be stayed, upheld, or vacated on appeal. Rescheduling isn’t truly settled until the courts finish — and that can add years.
The History Everyone Should Know Before Getting Their Hopes Up
Here’s the cautionary tale, and it’s a direct precedent. This is not the first time a DEA administrative law judge has held a hearing on marijuana rescheduling.
In the 1980s, the DEA ran essentially this same process. After the hearing, it took the judge two years to issue a recommendation. ALJ Francis Young then delivered one of the most famous lines in cannabis legal history, concluding that marijuana was “one of the safest therapeutically active substances known to man” and recommending rescheduling.
The DEA Administrator rejected the recommendation entirely. The D.C. Circuit upheld that rejection in 1994. From the hearing to the final court ruling, the whole affair consumed roughly a decade — and marijuana stayed in Schedule I. A judge recommending rescheduling is exactly what happened last time, and it changed nothing.
So when Julius issues his recommendation, remember: the Administrator can say no, and a court has blessed exactly that move before.
Why This Time Really Could Be Different
That precedent is sobering, but the current situation differs in ways that genuinely favor a faster, more durable outcome — and honesty requires laying these out too.
The biggest structural difference: last time, the government opposed rescheduling and the Administrator overruled his own judge. This time, the federal government is the proponent. An internal reversal like the 1980s would mean the DEA rejecting a rule it’s actively arguing for — far less likely. On top of that, a presidential executive order (signed December 2025) directs the Attorney General to complete rescheduling “in the most expeditious manner” allowed by law, the hearing ran on a compressed two-week schedule to honor that, and the scientific groundwork — HHS’s 2023 finding of accepted medical use for three conditions — is already built.
Stack those together and some cannabis attorneys think a final rule could publish in late 2026 or early 2027 if everything moves briskly. That would be lightning-fast by the standard of the 1980s saga — but note it’s still months away at minimum, not days.
The One Structural Weakness Worth Watching
There’s a subtle risk buried in the hearing’s design that could actually slow things down. Because the DEA invited only opponents to testify, the official record contains no organized pro-rescheduling voice besides the government itself. Some legal observers warn this could leave the administrative record thin when the final rule inevitably reaches a courtroom — a reviewing judge might find the record one-sided, giving challengers an opening to argue the process was inadequate. The structure that made the hearing fast could be the thing that makes the result fragile on appeal.
What To Actually Watch For
Forget July 15 as a decision day. The real dates to watch are: the post-hearing briefing deadline (a signal of pace), the ALJ’s recommended decision (the next true milestone, on no fixed schedule), and the final rule’s publication in the Federal Register (the moment anything legally changes). And through all of it, keep one eye on the D.C. Circuit, where the fight over April’s medical order is a preview of the litigation certain to greet any broader rule.
Rescheduling is coming — the momentum across all three branches is real, and this is the closest the country has come in fifty years. But it arrives by rulemaking, not by verdict. The hearing ending is the start of the next chapter, not the end of the story.
Circle the 15th if you like. Just don’t circle it in ink expecting an answer.
We’ll update this piece as each milestone lands after July 15. For the full background, see our coverage of the DEA hearing’s opening — and follow the rest at our Cannabis News hub.
Sources:
Federal Register — the DEA Notice of Hearing (primary source, docket DEA-1362): https://www.federalregister.gov/documents/2026/04/28/2026-08177/schedules-of-controlled-substances-rescheduling-of-marijuana
Vicente LLP (the post-hearing three-step process and the 1980s Francis Young precedent): https://vicentellp.com/insights/5-things-to-know-june-29-dea-cannabis-rescheduling-hearing/
Ohio State Moritz College of Law – Drug Enforcement and Policy Center (full rulemaking process and rescheduling timeline): https://moritzlaw.osu.edu/faculty-and-research/drug-enforcement-and-policy-center/research-and-grants/policy-and-data-analyses/federal-marijuana-rescheduling
Frantz Ward LLP (no immediate final rule expected, pending D.C. Circuit challenges): https://www.frantzward.com/two-months-out-continuing-developments-after-challenges-to-rescheduling-order-are-ongoing/
Cannabis Business Times (the thin-record judicial-review risk from the opponent-only hearing): https://www.cannabisbusinesstimes.com/cannabis-rescheduling/news/15828596/dea-judge-sets-cannabis-hearing-schedule-wont-consider-more-participants